• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 3. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 4. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonyl compounds Benzenesulfonyl halides

Recent Advances in the Application of 2,3,4-Trichlorobenzenesulfonyl Chloride (CAS: 34732-09-7) in Chemical Biology and Pharmaceutical Research

2,3,4-Trichlorobenzenesulfonyl chloride (CAS: 34732-09-7) is a key intermediate in the synthesis of various sulfonamide derivatives, which have shown significant potential in pharmaceutical and agrochemical applications. Recent studies have highlighted its role in the development of novel bioactive compounds, particularly in the context of antimicrobial and anticancer agents. This research brief aims to summarize the latest findings related to this compound, focusing on its synthetic utility, mechanism of action, and potential therapeutic applications.

One of the most notable advancements in the use of 2,3,4-trichlorobenzenesulfonyl chloride is its incorporation into the synthesis of sulfonamide-based inhibitors targeting bacterial enzymes. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent inhibitory activity against carbonic anhydrases from pathogenic bacteria, such as Mycobacterium tuberculosis. The study utilized X-ray crystallography to elucidate the binding modes of these inhibitors, providing valuable insights for the design of next-generation antibiotics.

In addition to its antimicrobial properties, 2,3,4-trichlorobenzenesulfonyl chloride has been explored as a building block for anticancer agents. Research published in Bioorganic & Medicinal Chemistry Letters in early 2024 reported the synthesis of sulfonamide hybrids that selectively target tumor-associated carbonic anhydrase isoforms. These hybrids demonstrated promising cytotoxicity against breast and lung cancer cell lines, with minimal effects on normal cells. The study emphasized the importance of the trichlorophenyl moiety in enhancing the selectivity and potency of these compounds.

Another emerging application of 2,3,4-trichlorobenzenesulfonyl chloride is in the development of fluorescent probes for biological imaging. A recent study in Chemical Communications described the synthesis of sulfonamide-based probes that selectively bind to amyloid aggregates, which are implicated in neurodegenerative diseases like Alzheimer's. The probes exhibited high sensitivity and specificity, making them valuable tools for early diagnosis and drug screening.

Despite these advancements, challenges remain in optimizing the pharmacokinetic properties of sulfonamide derivatives derived from 2,3,4-trichlorobenzenesulfonyl chloride. Issues such as poor solubility and metabolic instability have been reported in preclinical studies. However, ongoing research is addressing these limitations through structural modifications and formulation strategies. For instance, a 2024 patent application disclosed nanoparticle-based delivery systems designed to improve the bioavailability of these compounds.

In conclusion, 2,3,4-trichlorobenzenesulfonyl chloride continues to be a versatile and valuable intermediate in chemical biology and pharmaceutical research. Its applications span antimicrobial and anticancer drug development, as well as diagnostic tools for neurodegenerative diseases. Future research should focus on overcoming the current limitations and exploring new therapeutic targets for this compound and its derivatives.

• 2905-23-9(2-Chlorobenzenesulfonyl chloride)
• 51527-73-2(2,4,6-trichlorobenzene-1-sulfonyl chloride)
• 2888-06-4(3-Chlorobenzenesulfonyl chloride)
• 82417-45-6(2,3-dichlorobenzene-1-sulfonyl chloride)
• 6579-54-0(2,6-dichlorobenzene-1-sulfonyl chloride)
• 15945-07-0(2,4,5-Trichloro-benzenesulfonyl chloride)
• 16271-33-3(2,4-Dichlorobenzenesulfonyl chloride)
• 705-21-5(3,5-Dichlorobenzenesulfonyl chloride)
• 98-31-7(3,4-dichlorobenzene-1-sulfonyl chloride)
• 5402-73-3(2,5-Dichlorobenzenesulfonyl chloride)